ETF Holdings Breakdown of BHVN

Stock NameBiohaven Pharmaceutical Holding Co Ltd
TickerBHVN(USD) NYSE
TYPECommon Stock
CountryUSA
ISINVGG111961055
LEI5299007STZTNN32O9920

BHVN institutional holdings

The following institutional investment holdings of BHVN have been identified

Date ETF ISIN/Name Num Shares Book value
2025-10-17 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 62,927USD 1,003,686
2025-10-17 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 60,291USD 961,641
2025-10-17 IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) 7,058USD 112,575
Total =130,276 USD 2,077,902
Book value of shares is calculated on the adjusted close price of each day (row).

News associated with BHVN

Biohaven (NYSE:BHVN) and Celularity (NASDAQ:CELU) Head to Head Analysis
Celularity (NASDAQ:CELU – Get Free Report) and Biohaven (NYSE:BHVN – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, institutional ownership, valuation, profitability and risk. Volatility and Risk Celularity has a beta of 0.81, […] - 2025-09-17 02:58:44
BTIG Research Forecasts Strong Price Appreciation for Biohaven (NYSE:BHVN) Stock
Biohaven (NYSE:BHVN – Get Free Report) had its price target lifted by equities researchers at BTIG Research from $59.00 to $60.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm currently has a “buy” rating on the stock. BTIG Research’s target price indicates a potential upside of 309.14% from the stock’s previous […] - 2025-08-21 03:06:47
Biohaven (NYSE:BHVN) Price Target Cut to $52.00 by Analysts at Robert W. Baird
Biohaven (NYSE:BHVN – Get Free Report) had its target price reduced by Robert W. Baird from $57.00 to $52.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Robert W. Baird’s price objective would indicate a potential upside of 260.86% from the […] - 2025-08-14 02:52:59
Morgan Stanley Has Lowered Expectations for Biohaven (NYSE:BHVN) Stock Price
Biohaven (NYSE:BHVN – Get Free Report) had its target price lowered by Morgan Stanley from $63.00 to $54.00 in a research note issued to investors on Tuesday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. Morgan Stanley’s price objective would suggest a potential upside of 274.74% from the stock’s current price. Other […] - 2025-08-14 02:52:54
Bank of America Cuts Biohaven (NYSE:BHVN) Price Target to $49.00
Biohaven (NYSE:BHVN – Get Free Report) had its price objective reduced by investment analysts at Bank of America from $50.00 to $49.00 in a report released on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Bank of America‘s price target would suggest a potential upside of 240.04% from the stock’s previous […] - 2025-08-14 02:52:53
Biohaven Ltd. (NYSE:BHVN) Shares Sold by Universal Beteiligungs und Servicegesellschaft mbH
Universal Beteiligungs und Servicegesellschaft mbH trimmed its holdings in shares of Biohaven Ltd. (NYSE:BHVN – Free Report) by 21.4% during the first quarter, HoldingsChannel reports. The institutional investor owned 9,463 shares of the company’s stock after selling 2,569 shares during the quarter. Universal Beteiligungs und Servicegesellschaft mbH’s holdings in Biohaven were worth $227,000 at the […] - 2025-08-05 04:38:55
New York State Common Retirement Fund Has $3.85 Million Holdings in Biohaven Ltd. (NYSE:BHVN)
New York State Common Retirement Fund grew its position in Biohaven Ltd. (NYSE:BHVN – Free Report) by 589.9% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 160,251 shares of the company’s stock after purchasing an additional 137,024 shares during the […] - 2025-07-23 06:58:57
Jennison Associates LLC Has $451,000 Stock Position in Biohaven Ltd. (NYSE:BHVN)
Jennison Associates LLC lowered its position in shares of Biohaven Ltd. (NYSE:BHVN – Free Report) by 80.8% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 18,741 shares of the company’s stock after selling 78,791 shares during the quarter. Jennison Associates LLC’s holdings […] - 2025-07-23 06:21:00
Arizona State Retirement System Acquires 1,810 Shares of Biohaven Ltd. (NYSE:BHVN)
Arizona State Retirement System grew its position in shares of Biohaven Ltd. (NYSE:BHVN – Free Report) by 7.9% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 24,655 shares of the company’s stock after purchasing an additional 1,810 shares during the quarter. Arizona State […] - 2025-07-22 08:54:54
Biohaven Ltd. (NYSE:BHVN) Shares Acquired by Sigma Planning Corp
Sigma Planning Corp increased its holdings in Biohaven Ltd. (NYSE:BHVN – Free Report) by 32.4% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 10,862 shares of the company’s stock after purchasing an additional 2,661 shares during the quarter. Sigma Planning Corp’s holdings in Biohaven […] - 2025-07-21 05:31:03
Biohaven Ltd. (NYSE:BHVN) Receives $58.46 Average PT from Brokerages
Shares of Biohaven Ltd. (NYSE:BHVN – Get Free Report) have been given a consensus recommendation of “Buy” by the fifteen research firms that are presently covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a hold rating, twelve have given a buy rating and two have issued a strong buy rating […] - 2025-07-18 02:37:05
Analysts Set Biohaven Ltd. (NYSE:BHVN) Price Target at $58.46
Shares of Biohaven Ltd. (NYSE:BHVN – Get Free Report) have been given a consensus rating of “Buy” by the fifteen ratings firms that are presently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation, twelve have issued a buy recommendation and two have given a strong buy […] - 2025-06-23 02:14:04
JPMorgan Chase & Co. Lowers Biohaven (NYSE:BHVN) Price Target to $55.00
Biohaven (NYSE:BHVN – Get Free Report) had its price target reduced by stock analysts at JPMorgan Chase & Co. from $68.00 to $55.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s target price indicates a potential upside […] - 2025-06-20 02:56:57
Biohaven (NYSE:BHVN) Reaches New 1-Year Low Following Analyst Downgrade
Biohaven Ltd. (NYSE:BHVN – Get Free Report)’s stock price reached a new 52-week low during trading on Wednesday after JPMorgan Chase & Co. lowered their price target on the stock from $68.00 to $55.00. JPMorgan Chase & Co. currently has an overweight rating on the stock. Biohaven traded as low as $14.32 and last traded […] - 2025-06-20 02:08:58
California State Teachers Retirement System Purchases 7,005 Shares of Biohaven Ltd. (NYSE:BHVN)
California State Teachers Retirement System lifted its position in shares of Biohaven Ltd. (NYSE:BHVN – Free Report) by 10.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 74,144 shares of the company’s stock after purchasing an additional 7,005 […] - 2025-06-06 05:06:55
Biohaven Ltd. (NYSE:BHVN) Receives $59.46 Consensus Target Price from Analysts
Biohaven Ltd. (NYSE:BHVN – Get Free Report) has been assigned a consensus rating of “Buy” from the fifteen brokerages that are presently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation, twelve have given a buy recommendation and two have issued a strong buy recommendation on the company. […] - 2025-05-29 02:27:28
Two Sigma Advisers LP Trims Stake in Biohaven Ltd. (NYSE:BHVN)
Two Sigma Advisers LP cut its position in Biohaven Ltd. (NYSE:BHVN – Free Report) by 45.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 99,900 shares of the company’s stock after selling 84,300 shares during the quarter. Two Sigma Advisers […] - 2025-05-27 05:24:58
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Buys 13,147 Shares of Biohaven Ltd. (NYSE:BHVN)
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Biohaven Ltd. (NYSE:BHVN – Free Report) by 32.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 54,271 shares of the company’s stock after purchasing an additional 13,147 shares […] - 2025-05-22 05:52:58
Nuveen Asset Management LLC Has $34.33 Million Stake in Biohaven Ltd. (NYSE:BHVN)
Nuveen Asset Management LLC raised its position in Biohaven Ltd. (NYSE:BHVN – Free Report) by 55.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 919,235 shares of the company’s stock after purchasing an additional 326,636 shares during the quarter. Nuveen Asset Management LLC […] - 2025-05-21 05:11:02
Biohaven (NYSE:BHVN) Downgraded to Sector Perform Rating by Royal Bank of Canada
Royal Bank of Canada lowered shares of Biohaven (NYSE:BHVN – Free Report) from an outperform rating to a sector perform rating in a report issued on Monday, Marketbeat reports. They currently have $21.00 price objective on the stock, down from their prior price objective of $54.00. Several other equities analysts have also issued reports on […] - 2025-05-20 02:58:54
Ameriprise Financial Inc. Grows Holdings in Biohaven Ltd. (NYSE:BHVN)
Ameriprise Financial Inc. raised its stake in Biohaven Ltd. (NYSE:BHVN – Free Report) by 40.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 508,682 shares of the company’s stock after acquiring an additional 145,331 shares during the period. Ameriprise Financial Inc. owned approximately […] - 2025-05-16 06:02:48
Biohaven (NYSE:BHVN) Stock Price Down 5.3% Following Weak Earnings
Shares of Biohaven Ltd. (NYSE:BHVN – Get Free Report) traded down 5.3% during trading on Tuesday following a dissappointing earnings announcement. The stock traded as low as $19.33 and last traded at $19.48. 486,099 shares traded hands during mid-day trading, a decline of 58% from the average session volume of 1,169,407 shares. The stock had […] - 2025-05-15 02:40:44
Biohaven Ltd. (NYSE:BHVN) Receives Average Recommendation of “Buy” from Analysts
Shares of Biohaven Ltd. (NYSE:BHVN – Get Free Report) have been given a consensus recommendation of “Buy” by the fifteen brokerages that are covering the company, Marketbeat Ratings reports. Fourteen equities research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 […] - 2025-05-01 02:12:47
Robert W. Baird Has Lowered Expectations for Biohaven (NYSE:BHVN) Stock Price
Biohaven (NYSE:BHVN – Get Free Report) had its price objective reduced by investment analysts at Robert W. Baird from $60.00 to $57.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Robert W. Baird’s target price suggests a potential upside of 160.39% from the […] - 2025-04-30 03:00:48
Biohaven Sees Unusually Large Options Volume (NYSE:BHVN)
Biohaven Ltd. (NYSE:BHVN – Get Free Report) saw unusually large options trading on Tuesday. Traders purchased 7,638 call options on the stock. This represents an increase of 588% compared to the typical daily volume of 1,110 call options. Biohaven Trading Up 2.7 % Shares of NYSE:BHVN opened at $21.10 on Wednesday. The company has a […] - 2025-04-23 02:28:49
Barclays PLC Has $14.67 Million Stock Position in Biohaven Ltd. (NYSE:BHVN)
Barclays PLC boosted its stake in shares of Biohaven Ltd. (NYSE:BHVN – Free Report) by 46.5% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 392,727 shares of the company’s stock after buying an additional 124,650 shares during the period. Barclays PLC […] - 2025-04-21 06:12:48
Summit Investment Advisors Inc. Has $336,000 Stake in Biohaven Ltd. (NYSE:BHVN)
Summit Investment Advisors Inc. increased its holdings in shares of Biohaven Ltd. (NYSE:BHVN – Free Report) by 18.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 8,985 shares of the company’s stock after acquiring an additional 1,378 shares during the quarter. Summit Investment […] - 2025-04-21 04:56:55
Federated Hermes Inc. Trims Stock Holdings in Biohaven Ltd. (NYSE:BHVN)
Federated Hermes Inc. reduced its holdings in shares of Biohaven Ltd. (NYSE:BHVN – Free Report) by 41.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,753 shares of the company’s stock after selling 8,869 shares during the quarter. Federated Hermes Inc.’s holdings […] - 2025-04-18 05:26:52
Notable Thursday Option Activity: CELH, AMD, BHVN
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Celsius Holdings Inc (Symbol: CELH), where a total volume of 78,165 contracts has been traded thus far today, a contract volume which is representative of approx - 2025-04-17 16:22:18
Biohaven Ltd. (NYSE:BHVN) Shares Sold by Russell Investments Group Ltd.
Russell Investments Group Ltd. reduced its position in Biohaven Ltd. (NYSE:BHVN – Free Report) by 10.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 146,125 shares of the company’s stock after selling 16,752 shares during the quarter. Russell Investments Group Ltd.’s holdings in Biohaven […] - 2025-04-15 06:12:54

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.